UBI Pharma, Inc. engages in the research, development, manufacture and sale of non-antibody protein drugs, small molecule new drugs and special medicine. Its products include Ubixa film coated tablets, levetiracetam concentrate solution, and lamivudine film coated tablets. It also provides commissioned drug manufacturing and technical services. The company was founded by Yi Cheng Wang on July 31, 2014 and is headquartered in Hsinchu, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company